Sustained Benefit at 2 Years for Covered Stents Versus Bare-Metal Stents in Long SFA Lesions: The VIASTAR Trial

Johannes Lammer,Thomas Zeller,K. A. Hausegger,Philipp J. Schaefer,Manfred Gschwendtner,Stefan Mueller-Huelsbeck,Thomas Rand,Martin Funovics,Florian Wolf,Aljoscha Rastan,Michael E. Gschwandtner,Stefan Puchner,Ulrich Beschorner,Robin Ristl,Maria Schoder

Sustained Benefit at 2 Years for Covered Stents Versus Bare-Metal Stents in Long SFA Lesions: The VIASTAR Trial

2015

Johannes Lammer
Thomas Zeller
K. A. Hausegger
Philipp J. Schaefer
Manfred Gschwendtner
Stefan Mueller-Huelsbeck
Thomas Rand
Martin Funovics
Florian Wolf
Aljoscha Rastan
Michael E. Gschwandtner
Stefan Puchner
Ulrich Beschorner
Robin Ristl
Maria Schoder

Purpose The hypothesis that covered stents are superior to bare-metal stents (BMS) in long femoropopliteal artery disease was tested. The one-year results of the VIASTAR trial revealed a patency benefit of covered stents in the treatment-per-protocol (TPP) analysis only.

Keywords:

Cardiology
Radiology
Internal medicine
Stent
Medicine
bare metal
Lesion
covered stent
Log-rank test
Artery
Ankle
after treatment

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations